1. Home
  2. Analysis
  3. Celecoxib
  4. Pyoderma-streptococcal

Celecoxib and Pyoderma streptococcal - a phase IV clinical study of FDA data

Summary:

Pyoderma streptococcal is reported as a side effect among people who take Celecoxib (celecoxib), especially for people who are male, 30-39 old, also take Cosentyx, and have Psoriasis.

The phase IV clinical study analyzes which people have Pyoderma streptococcal when taking Celecoxib. It is created by eHealthMe based on reports of 37,974 people who have side effects when taking Celecoxib from the FDA, and is updated regularly.

What is Celecoxib?

Celecoxib has active ingredients of celecoxib. It is often used in arthritis. eHealthMe is studying from 38,217 Celecoxib users. Check the latest studies of Celecoxib.

What is Pyoderma streptococcal?

Pyoderma streptococcal (streptococcal skin infections) is found to be associated with 11 drugs and 14 conditions by eHealthMe. Check the latest studies of Pyoderma streptococcal.

On Jul, 21, 2026

37,974 people reported to have side effects when taking Celecoxib.
Among them, 13 people (0.03%) have Pyoderma streptococcal.

Could Celecoxib cause Pyoderma streptococcal?

Among these 13 people:

What is the gender of people who have Pyoderma streptococcal when taking Celecoxib? *

  • female: 0.0 %
  • male: 100 %

What is the age of people who have Pyoderma streptococcal when taking Celecoxib? *

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 100 %
  • 40-49: 0.0 %
  • 50-59: 0.0 %
  • 60+: 0.0 %

What are other drugs people take besides Celecoxib? *

  1. Stelara: 13 people, 100.00%
  2. Cosentyx: 13 people, 100.00%
  3. Lidoderm: 12 people, 92.31%
  4. Taltz: 7 people, 53.85%
  5. Clotrimazole: 2 people, 15.38%
  6. Betamethasone Valerate: 1 person, 7.69%

What are other side effects people have besides Pyoderma streptococcal? *

  1. High Blood Pressure: 13 people, 100.00%
  2. Lymph Follicular Hypertrophy (an increase in the size of the lymph node follicles): 13 people, 100.00%
  3. Chronic Obstructive Pulmonary Disease (a progressive disease that makes it hard to breathe): 13 people, 100.00%
  4. Cough: 13 people, 100.00%
  5. Diabetes: 13 people, 100.00%
  6. Dyspnea (difficult or laboured breathing): 13 people, 100.00%
  7. Enlarged Prostate: 13 people, 100.00%
  8. Fungal Skin Infection: 13 people, 100.00%
  9. Urinary Tract Infection: 13 people, 100.00%
  10. Cellulitis (infection under the skin): 13 people, 100.00%

What are the existing conditions these people have? *

  1. Psoriasis (immune-mediated disease that affects the skin): 13 people, 100.00%

* Approximation only. Some reports may have incomplete information.

Do you take Celecoxib and have Pyoderma streptococcal?

- Check whether Pyoderma streptococcal is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Celecoxib:

Pyoderma streptococcal treatments and more:

How severe was Pyoderma streptococcal and when was it recovered:

Expand to all the drugs that have ingredients of celecoxib:

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Celecoxib:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Pyoderma streptococcal:

Browse all the conditions that are associated with Pyoderma streptococcal:

How the study uses the data?

The study uses data from the FDA. It is based on celecoxib (the active ingredients of Celecoxib) and Celecoxib (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe:

© 2026 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.